Estados Unidos - inglês - NLM (National Library of Medicine)

par pharmaceutical, inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - aspirin 25 mg - aspirin and extended-release dipyridamole capsule is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. aspirin and extended-release dipyridamole is contraindicated in patients with known hypersensitivity to any of the product components. aspirin is contraindicated in patients with known allergy to nonsteroidal anti-in aspirin is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug (nsaid) products and in patients with the syndrome of asthma, rhinitis, and nasal polyps. aspirin may cause severe urticaria, angioedema or bronchospasm. do not use aspirin in children or teenagers with viral infections because of the risk of reye syndrome. risk summary available data from published studies and postmarketing experience with aspirin and extended-release dipyridamole use during pregnancy have not identified a clear association between aspirin and extended-release dipyridamole use and major bir

Estados Unidos - inglês - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - aspirin 25 mg - aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. aspirin and extended-release dipyridamole capsules are contraindicated in patients with known hypersensitivity to any of the product components. aspirin is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug (nsaid) products and in patients with the syndrome of asthma, rhinitis, and nasal polyps. aspirin may cause severe urticaria, angioedema or bronchospasm. do not use aspirin in children or teenagers with viral infections because of the risk of reye syndrome. teratogenic effects , pregnancy category d. [see warnings and precautions (5.4) ]. aspirin can result in excessive blood loss at delivery as well as prolonged gestation and prolonged labor. because of these effects on the mother and because of adverse fetal effects seen with aspirin during the later stages of pregnancy [se

Estados Unidos - inglês - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - aspirin 25 mg - aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. aspirin and extended-release dipyridamole capsules are contraindicated in patients with known hypersensitivity to any of the product components. aspirin is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug (nsaid) products and in patients with the syndrome of asthma, rhinitis, and nasal polyps. aspirin may cause severe urticaria, angioedema or bronchospasm. do not use aspirin in children or teenagers with viral infections because of the risk of reye syndrome. risk summary available data from published studies and postmarketing experience with aspirin and extended-release dipyridamole capsule use during pregnancy have not identified a clear association between aspirin and extended-release dipyridamole capsule use and major birth defects, miscarriage, or adverse maternal or fetal

Estados Unidos - inglês - NLM (National Library of Medicine)

cardinal health, inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - aspirin 325 mg - pain reliever temporarily relieves - headache - muscle pain - toothache - menstrual pain - pain and fever of colds - minor pain of arthritis do not use if you are allergic to aspirin or any other pain reliever/fever reducer. stop use and ask a doctor if - an allergic reaction occurs. seek medical help right away. - you experience any of the following signs of stomach bleeding: •feel faint •have bloody or black stools •vomit blood •have stomach pain that does not get better - new symptoms occur - pain gets worse or lasts more than 10 days - redness or swelling is present - fever lasts more than 3 days - ringing in the ears or a loss of hearing occurs

Estados Unidos - inglês - NLM (National Library of Medicine)

zydus lifesciences limited - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - aspirin 25 mg - aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. aspirin and extended-release dipyridamole capsules are contraindicated in patients with known hypersensitivity to any of the product components. aspirin is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug (nsaid) products and in patients with the syndrome of asthma, rhinitis, and nasal polyps. aspirin may cause severe urticaria, angioedema or bronchospasm. do not use aspirin in children or teenagers with viral infections because of the risk of reye syndrome. risk summary available data from published studies and postmarketing experience with aspirin and extended-release dipyridamole capsule use during pregnancy have not identified a clear association between aspirin and extended-release dipyridamole capsule use and major birth defects, miscarriage, or adverse maternal or fetal

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - aspirin,dipyridamole -

Malásia - inglês - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - aspirin -

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

bayer new zealand limited - aspirin 300mg - tablet - 300 mg - active: aspirin 300mg

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

multichem nz limited - aspirin 300mg;   - dispersible tablet - 300 mg - active: aspirin 300mg   excipient: colloidal silicon dioxide hyprolose lactose monohydrate maize starch stearic acid

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - aspirin 300mg - soluble tablet - 300 mg - active: aspirin 300mg excipient: calcium carbonate citric acid monohydrate isopropyl alcohol purified talc saccharin sodium sodium laurilsulfate wheat starch